Methods and compositions for modifying shade avoidance in plants
US-2024279673-A1 · Aug 22, 2024 · US
US12378613B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12378613-B2 |
| Application number | US-202418421579-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 24, 2024 |
| Priority date | Nov 2, 2006 |
| Publication date | Aug 5, 2025 |
| Grant date | Aug 5, 2025 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Methods and kits are described for testing for the presence or absence of any fungus in a sample. Examples of fungi that can be detected include, but are not limited to, those belonging to the genera Candida, Aspergillus and Pneumocystis . The methods include obtaining a sample suspected of containing fungal nucleic acid, including at least one universal region of fungal nucleic acid, and testing for the presence or absence in the sample of the at least one universal region of fungal nucleic acid. Samples may be biological or non-biological.
Opening claim text (preview).
We claim: 1. A kit for testing for the presence or absence of at least one region of fungal nucleic acid characteristic of the genus Pneumocystis in a sample comprising a molecular beacon probe comprising SEQ ID NO: 21 and a pair of primers comprising SEQ ID NO: 19 and SEQ ID NO: 20. 2. The kit of claim 1 , wherein the at least one region of fungal nucleic acid characteristic of the genus Pneumocystis includes SEQ ID NO: 18, a complement or transcript thereof, or a sequence having 80% or more sequence homology with SEQ ID NO: 18, complement or transcript thereof. 3. The kit of claim 1 , wherein the at least one region of fungal nucleic acid is characteristic of Pneumocystis jirovecii. 4. The kit of claim 1 , wherein the sample is a human clinical sample. 5. The kit of claim 1 further comprising one or more internal PCR amplification controls. 6. A kit for testing for the presence or absence of at least one region of fungal nucleic acid comprising SEQ ID NO: 18, the complement or transcript thereof, or a sequence having 80% or more sequence identity with SEQ ID NO: 18, the complement or transcript thereof, in a human clinical sample comprising a molecular beacon probe comprising SEQ ID NO: 21 and a pair of primers comprising SEQ ID NO: 19 and SEQ ID NO: 20. 7. The kit of claim 6 , wherein the at least one region of fungal nucleic acid is characteristic of Pneumocystis jirovecii. 8. The kit of claim 6 , further comprising one or more internal PCR amplification controls.
Oligonucleotides used as internal standards, controls or normalisation probes · CPC title
Primer sets for multiplex assays · CPC title
for plants, fungi or algae · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.